The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing
Open accessAbstract
Anaplastic thyroid carcinoma (ATC) is a frequently lethal malignancy that is often unresponsive to available therapeutic strategies. The tumorigenesis of ATC and its relationship to the widely prevalent well-differentiated thyroid carcinomas are unclear. We have analyzed 22 cases of ATC as well as 4 established ATC cell lines using whole-exome sequencing. A total of 2674 somatic mutations (121/sample) were detected. Ontology analysis revealed that the majority of variants aggregated in the MAPK, ErbB and RAS signaling pathways. Mutations in genes related to malignancy not previously associated with thyroid tumorigenesis were observed, including mTOR, NF1, NF2, MLH1, MLH3, MSH5, MSH6, ERBB2, EIF1AX and USH2A; some of which were recurrent and were investigated in 24 additional ATC cases and 8 ATC cell lines. Somatic mutations in established thyroid cancer genes were detected in 14 of 22 (64%) tumors and included recurrent mutations in BRAF, TP53 and RAS-family genes (6 cases each), as well as PIK3CA (2 cases) and single cases of CDKN1B, CDKN2C, CTNNB1 and RET mutations. BRAF V600E and RAS mutations were mutually exclusive; all ATC cell lines exhibited a combination of mutations in either BRAF and TP53 or NRAS and TP53. A hypermutator phenotype in two cases with >8 times higher mutational burden than the remaining mean was identified; both cases harbored unique somatic mutations in MLH mismatch-repair genes. This first comprehensive exome-wide analysis of the mutational landscape of ATC identifies novel genes potentially associated with ATC tumorigenesis, some of which may be targets for future therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
MutationTaster2: mutation prediction for the deep-sequencing age
Schwarz, J. M., Cooper, D. N., Schuelke, M., & Seelow, D. (2014) · Nature Methods · doi:10.1038/nmeth.2890 · Cited by 3,362
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Agrawal, N., Akbani, R., Aksoy, B. A., Ally, A., Arachchi, H., Asa, S. L., Auman, J. T., Balasundaram, M., Balu, S., Baylin, S. B., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.050 · Cited by 3,062
Self-citationMolecular pathogenesis and mechanisms of thyroid cancer
Xing, M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3431 · Cited by 1,426
The ErbB/HER family of protein-tyrosine kinases and cancer
Roskoski, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.002 · Cited by 1,353
Genetic diagnosis by whole exome capture and massively parallel DNA sequencing
Choi, M., Scholl, U. I., Ji, W., Liu, T., Tikhonova, I. R., Zumbo, P., Nayir, A., Bakkaloğlu, A., Özen, S., Sanjad, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910672106 · Cited by 1,329
Self-citationExome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Krauthammer, M., Kong, Y., Ha, B. H., Evans, P., Bacchiocchi, A., McCusker, J. P., Cheng, E., Davis, M. J., Goh, G., Choi, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2359 · Cited by 1,191
Self-citationSignaling cross-talk between TGF-β/BMP and other pathways
Guo, X., & Wang, X.-F. (2009) · Cell Research · doi:10.1038/cr.2008.302 · Cited by 1,015
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
Smallridge, R. C., Ain, K. B., Asa, S. L., Bible, K. C., Brierley, J. D., Burman, K. D., Kebebew, E., Lee, N. Y., Nikiforov, Y. E., Rosenthal, M. S., et al. (2012) · Thyroid · doi:10.1089/thy.2012.0302 · Cited by 935
Anaplastic thyroid carcinoma: Treatment outcome and prognostic factors
Kebebew, E., Greenspan, F. S., Clark, O. H., Woeber, K. A., & McMillan, A. (2005) · Cancer · doi:10.1002/cncr.20936 · Cited by 666
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
Fagin, J. A., Matsuo, K., Karmakar, A., Chen, D. L., Tang, S. H., & Koeffler, H. P. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116168 · Cited by 649
Schweppe, R. E., Klopper, J. P., Korch, C., Pugazhenthi, U., Benezra, M., Knauf, J. A., Fagin, J. A., Marlow, L. A., Copland, J. A., Smallridge, R. C., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1102 · Cited by 563
Martin, M., Maßhöfer, L., Temming, P., Rahmann, S., Metz, C., Bornfeld, N., van de Nes, J., Klein-Hitpass, L., Hinnebusch, A. G., Horsthemke, B., et al. (2013) · Nature Genetics · doi:10.1038/ng.2674 · Cited by 542
Ricarte-Filho, J. C., Ryder, M., Chitale, D. A., Rivera, M., Heguy, A., Ladanyi, M., Janakiraman, M., Solit, D., Knauf, J. A., Tuttle, R. M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0727 · Cited by 529
Whole-exome sequencing identifies recessive WDR62 mutations in severe brain malformations
Bilgüvar, K., Öztürk, A. K., Louvi, A., Kwan, K. Y., Choi, M., Tatlı, B., Yalnızoğlu, D., Tüysüz, B., Çağlayan, A. O., Gökben, S., et al. (2010) · Nature · doi:10.1038/nature09327 · Cited by 503
Self-citationAnaplastic carcinoma of the thyroid: A clinicopathologic study of 121 cases
Venkatesh, Y. S. S., Ordonez, N. G., Schultz, P. N., Hickey, R. C., Goepfert, H., & Samaan, N. A. (1990) · Cancer · doi:10.1002/1097-0142(19900715)66:2<321::aid-cncr2820660221>3.0.co;2-a · Cited by 486
Anaplastic thyroid carcinoma: A 50-year experience at a single institution
McIver, B., HAY, I. D., Giuffrida, D., et al. (2001) · Surgery · doi:10.1067/msy.2001.118266 · Cited by 484
Human cancers express mutator phenotypes: origin, consequences and targeting
Loeb, L. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3063 · Cited by 396
Mutation of a Gene Encoding a Protein with Extracellular Matrix Motifs in Usher Syndrome Type IIa
Eudy, J. D., Weston, M. D., Yao, S., Hoover, D. M., Rehm, H. L., Ma-Edmonds, M., Yan, D., Ahmad, I., Cheng, J. J., Ayuso, C., et al. (1998) · Science · doi:10.1126/science.280.5370.1753 · Cited by 396
Liu, Z., Hou, P., Ji, M., Guan, H., Studeman, K., Jensen, K., Vasko, V., El-Naggar, A. K., & Xing, M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0273 · Cited by 390
Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
Smallridge, R. C., Marlow, L. A., & Copland, J. A. (2009) · Endocrine-Related Cancer · doi:10.1677/erc-08-0154 · Cited by 390
ras Mutations Are Associated With Aggressive Tumor Phenotypes and Poor Prognosis in Thyroid Cancer
Garcia-Rostan, G., Zhao, H., Camp, R. L., Pollan, M., Herrero, A., Pardo, J., Wu, R., Carcangiu, M. L., Costa, J., & Tallini, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.130 · Cited by 368
Response and Acquired Resistance to Everolimus in Anaplastic Thyroid Cancer
Wagle, N., Grabiner, B. C., Van Allen, E. M., Amin-Mansour, A., Taylor-Weiner, A., Rosenberg, M., Gray, N., Barletta, J. A., Guo, Y., Swanson, S. J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403352 · Cited by 321
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma
Zhao, S., Choi, M., Overton, J. D., Bellone, S., Roque, D. M., Cocco, E., Guzzo, F., English, D. P., Varughese, J., Gasparrini, S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222577110 · Cited by 320
Self-citationFrequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma.
Garcia-Rostan, G., Tallini, G., Herrero, A., D'Aquila, T. G., Carcangiu, M. L., & Rimm, D. L. (1999) · PubMed · Cited by 308
Self-citationFrequent mutation and nuclear localization of betacatenin in anaplastic thyroid carcinoma
Gineza, G. (1999) · Cancer Research · Cited by 303
β-Catenin Dysregulation in Thyroid Neoplasms
Garcia-Rostan, G., Camp, R. L., Herrero, A., Carcangiu, M. L., Rimm, D. L., & Tallini, G. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64045-x · Cited by 277
Self-citationKelly, L. M., Barila, G., Liu, P., Evdokimova, V. N., Trivedi, S., Panebianco, F., Gandhi, M., Carty, S. E., Hodak, S. P., Luo, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321937111 · Cited by 271
Nikiforov, Y. E. (2004) · Endocrine Pathology · doi:10.1385/ep:15:4:319 · Cited by 234
Anaplastic carcinoma of the thyroid
Lo, C.-Y., Lam, K.-Y., & Wan, K.-Y. (1999) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)00052-5 · Cited by 208
Santarpia, L., El-Naggar, A. K., Cote, G. J., Myers, J. N., & Sherman, S. I. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1076 · Cited by 208
Integration of TGF-ß and Ras/MAPK Signaling Through p53 Phosphorylation
Cordenonsi, M., Montagner, M., Adorno, M., Zacchigna, L., Martello, G., Mamidi, A., Soligo, S., Dupont, S., & Piccolo, S. (2007) · Science · doi:10.1126/science.1135961 · Cited by 203
Mutator Phenotypes Conferred by MLH1 Overexpression and by Heterozygosity for mlh1 Mutations
Shcherbakova, P. V., & Kunkel, T. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.3177 · Cited by 189
Ragazzi, M., Ciarrocchi, A., Sancisi, V., Gandolfi, G., Bisagni, A., & Piana, S. (2014) · International Journal of Endocrinology · doi:10.1155/2014/790834 · Cited by 187
Lam, K.-Y., Lo, C.-Y., Chan, K.-W., & Wan, K.-Y. (2000) · Annals of Surgery · doi:10.1097/00000658-200003000-00005 · Cited by 182
BRAF V600E Inhibition in Anaplastic Thyroid Cancer
Rosove, M. H., Peddi, P. F., & Glaspy, J. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1215697 · Cited by 179
Recent developments in prognostic and predictive testing in uveal melanoma
Field, M. G., & Harbour, J. W. (2014) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000051 · Cited by 167
McFadden, D. G., Vernon, A., Santiago, P. M., Martinez-McFaline, R., Bhutkar, A., Crowley, D. M., McMahon, M., Sadow, P. M., & Jacks, T. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404357111 · Cited by 166
Vater, I., Montesinos-Rongen, M., Schlesner, M., Haake, A., Purschke, F., Sprute, R., Mettenmeyer, N., Nazzal, I., Nagel, I., Gutwein, J., et al. (2015) · Leukemia · doi:10.1038/leu.2014.264 · Cited by 166
Ewens, K. G., Kanetsky, P. A., Richards-Yutz, J., Purrazzella, J., Shields, C. L., Ganguly, T., & Ganguly, A. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.14-14550 · Cited by 158
Ross, J. S., Wang, K., Gay, L. M., Al-Rohil, R. N., Nazeer, T., Sheehan, C. E., Jennings, T. A., Otto, G. A., Donahue, A. L., He, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1992 · Cited by 158
Tumor Mutation Burden Forecasts Outcome in Ovarian Cancer with BRCA1 or BRCA2 Mutations
Birkbak, N. J., Kochupurakkal, B. S., Izarzugaza, J. M. G., Eklund, A. C., Li, Y., Liu, J. F., Szállási, Z., Matulonis, U. A., Richardson, A. L., Iglehart, J. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080023 · Cited by 154
Identification of Somatic Mutations in Parathyroid Tumors Using Whole-Exome Sequencing
Cromer, M. K., Starker, L. F., Choi, M., Udelsman, R., Nelson-Williams, C. J., Lifton, R. P., & Carling, T. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1743 · Cited by 148
Self-citationActivating BRAF and PIK3CA Mutations Cooperate to Promote Anaplastic Thyroid Carcinogenesis
Charles, R., Silva, J. M., Iezza, G., Phillips, W. A., & McMahon, M. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0158-t · Cited by 109
Pita, J. M. G., Figueiredo, I., Moura, M. M., Leite, V. A. P. H., & Cavaco, B. M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1512 · Cited by 103
Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review
Guerra, A., Crescenzo, V. G. D., Garzi, A., Cinelli, M., Carlomagno, C., Tonacchera, M., Zeppa, P., & Vitale, M. (2013) · BMC Surgery · doi:10.1186/1471-2482-13-s2-s44 · Cited by 98
Dysregulation of the Phosphatidylinositol 3-Kinase Pathway in Thyroid Neoplasia
Paes, J. E., & Ringel, M. D. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.01.001 · Cited by 96
Identification of a Recurrent STRN/ALK Fusion in Thyroid Carcinomas
Pérot, G., Soubeyran, I., Ribeiro, A., Bonhomme, B., Savagner, F., Boutet-Bouzamondo, N., Hostein, I., Bonichon, F., Godbert, Y., & Chibon, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087170 · Cited by 94
Somatic Mutaome Profile in Human Cancer Tissues
Kim, N., Hong, Y., Kwon, D., & Yoon, S. (2013) · Genomics & Informatics · doi:10.5808/gi.2013.11.4.239 · Cited by 87
Identification of RASAL1 as a Major Tumor Suppressor Gene in Thyroid Cancer
Liu, D., Yang, C., Bojdani, E., Murugan, A. K., & Xing, M. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt249 · Cited by 86
Jin, N. Y., Jiang, T., Rosen, D. M., Nelkin, B. D., & Ball, D. W. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0662 · Cited by 78
Activating mutations of TOR (target of rapamycin)
Hardt, M. E., Chantaravisoot, N., & Tamanoi, F. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01482.x · Cited by 76
Yoshida, R., Miyashita, K., Inoue, M., Shimamoto, A., Yan, Z., Egashira, A., Oki, E., Kakeji, Y., Oda, S., & Maehara, Y. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.216 · Cited by 75
Wennerberg, E., Pfefferle, A., Ekblad, L., Yoshimoto, Y., Kremer, V., Kaminskyy, V. O., Juhlin, C. C., Höög, A., Bodin, I., Svjatoha, V., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0291 · Cited by 65
Self-citationKurihara, T., Ikeda, S., Ishizaki, Y., Fujimori, M., Tokumoto, N., Hirata, Y., Ozaki, S., Okajima, M., Sugino, K., & Asahara, T. (2004) · Thyroid · doi:10.1089/thy.2004.14.1020 · Cited by 62
Milosevic, Z. C., Pešić, M., Stanković, T., Dinić, J., Milovanović, Z., Stojšić, J. M., Džodić, R. R., Tanić, N., & Banković, J. (2014) · Translational research · doi:10.1016/j.trsl.2014.06.005 · Cited by 56
Molecular Cytogenetic Profiles of Novel and Established Human Anaplastic Thyroid Carcinoma Models
Lee, J.-J., Foukakis, T., Hashemi, J., Grimelius, L., Heldin, N., Wallin, G., Rudduck, C., Lui, W., Höög, A., & Larsson, C. (2007) · Thyroid · doi:10.1089/thy.2006.0246 · Cited by 51
Self-citationDeep Clonal Profiling of Formalin Fixed Paraffin Embedded Clinical Samples
Holley, T., Lenkiewicz, E., Evers, L., Tembe, W., Ruiz, C. F., Gsponer, J. R., Rentsch, C. A., Bubendorf, L., Stapleton, M., Amorese, D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050586 · Cited by 48
Menon, R., Deng, M., Boehm, D., Braun, M., Fend, F., Böhm, D., Biskup, S., & Perner, S. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13078933 · Cited by 32
Yu, C., Luo, C., Qu, B., Khudhair, N., Gu, X., Zang, Y., Wang, C., Zhang, N., Li, Q., & Gao, X. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.09.014 · Cited by 27
Stulp, R. P., Herkert, J. C., Karrenbeld, A., Mol, B., Vos, Y. J., & Sijmons, R. H. (2008) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-6-1-15 · Cited by 26
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Landa, I., Ibrahimpasic, T., Boucai, L., Sinha, R., Knauf, J. A., Shah, R. H., Dogan, S., Ricarte-Filho, J. C., Krishnamoorthy, G. P., Xu, B., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85271 · Cited by 1,284
Overview of the 2022 WHO Classification of Thyroid Neoplasms
Baloch, Z. W., Asa, S. L., Barletta, J. A., Ghossein, R. A., Juhlin, C. C., Jung, C. K., LiVolsi, V. A., Papotti, M. G., Sobrinho-Simões, M., Tallini, G., et al. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09707-3 · Cited by 1,158
Self-citationSubbiah, V., Kreitman, R. J., Wainberg, Z. A., Cho, J. Y., Schellens, J. H. M., Soria, J. C., Wen, P. Y., Zielinski, C., Cabanillas, M. E., Urbanowitz, G., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.6785 · Cited by 892
Bible, K. C., Kebebew, E., Brierley, J., Brito, J. P., Cabanillas, M. E., Clark, T. J., Di Cristofano, A., Foote, R., Giordano, T., Kasperbauer, J., et al. (2021) · Thyroid · doi:10.1089/thy.2020.0944 · Cited by 730
Metadata
- Authors
- Kunstman, J. W., Juhlin, C. C., Goh, G., Brown, T. C., Stenman, A., Healy, J. M., Rubinstein, J. C., Choi, M., Kiss, N., Nelson-Williams, C., Mane, S., Rimm, D. L., Prasad, M. L., Höög, A., Zedenius, J., Larsson, C., Korah, R., Lifton, R. P., & Carling, T.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-01-09
- Volume
- 24
- Issue
- 8
- Pages
- 2318-2329
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W1971381075
- Cited by
- 364
- References
- 61
- FWCI
- 27.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.